Serum KL-6 as a possible marker for amiodarone-induced pulmonary toxicity

Internal Medicine

Volumn 39, Issue 12, 2000, Pages 1097-1100

  Nakajima, Masamitsu ^a   Kawahara, Yousuke ^a   Yoshida, Kouichirou ^a   Miyashita, Naoyuki ^a   Niki, Yoshihito ^a   Matsushima, Toshiharu ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Drug induced pneumonia; MUC 1; Type II pneumocyte

Indexed keywords

AMIODARONE; GLYCOPROTEIN; GLYCOPROTEIN KL 6; MARKER; UNCLASSIFIED DRUG;

ADULT; ARTERIAL OXYGEN TENSION; ARTICLE; CASE REPORT; HEART VENTRICLE EXTRASYSTOLE; HUMAN; LUNG ALVEOLUS CELL TYPE 2; LUNG DIFFUSION CAPACITY; LUNG TOXICITY; MALE; THORAX RADIOGRAPHY;

EID: 0034521802     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.39.1097     Document Type: Article

References (13)

1. Dusman RE, Stanton MS, Miles WM, et al. Clinical features of amiodarone-induced pulmonary toxicity. Circulation. 82: 51-59, 1990.
2. Pollak PT. Clinical organ toxicity of antiarrhythmic compounds: ocular and pulmonary manifestations. Am J Cardiol 84: 37R-45R, 1999.
3. Jessurun GA, Crijns HJ. Amiodarone pulmonary toxicity. BMJ 314:619-620, 1997.
4. Nakajima M, Manabe T, Mitekura H, Hashiguchi K, Niki Y, Matsushima T. Levels of serum KL-6 in a patient with drug-Induced Pneumonitis. Nihon-Kyobu-Shikkan-Gakkai-Zasshi 35: 813-817, 1997 (in Japanese with English Abstract).
5. Liu FL, Cohen RD, Downar E, Butany JW, Edelson JD, Rebuck AS. Amiodarone pulmonary toxicity: functional and ultrastructural evaluation. Thorax 41: 100-105, 1986.
6. Myers JL, Kennedy JI, Plumb VJ. Amiodarone lung: pathologic findings in clinically toxic patients. Hum Pathol 18: 349-359, 1987.
7. Gleadhill IC, Wise RA, Schonfeld SA, et al. Serial lung function testing in patients treated with amiodarone: a prospective study. Am J Med 86: 4-10, 1989.
8. Kohno N, Koizumi S, Awaya Y, Fukuhara H, Yamakido M, Akiyama M. New serum indicator of interstitial pneumonitis activity: sialylated carbohydrate antigen KL-6. Chest 96: 68-73, 1989.
9. Kobayashi J, Kitamura S. KL-6: a serum marker for interstitial pneumonia. Chest 108: 311-315, 1995.
10. Nakajima M, Toshiaki M, Yoshida K, Niki Y, Matsushima T. Evaluation of serum KL-6 levels in summer-type hypersensitivity pneumonitis. Nihon-Kokyuki-Gakkai-Zasshi 36: 763-770, 1998 (in Japanese with English Abstract).
11. Kohno N, Inoue Y, Hamada H, et al. Difference in sero-diagnostic values among KL-6-associated mucins classified as cluster 9. Int J Cancer Suppl 8:81-83, 1994.
12. Nakajima M, Manabe T, Niki Y, Matsushima T. Serum Kl-6 level as a monitoring marker in a patient with pulmonary alveolar proteinosis. Thorax 53: 809-811, 1998.
13. Kennedy JI, Myers JL, Plumb VJ, Fulmer JD. Amiodarone pulmonary toxicity. Clinical, radiologic, and pathologic correlations. Arch Intern Med 147: 50-55, 1987.